Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBadr Al Bawardy, MD
Assistant Professor Adjunct of Medicine (Digestive Diseases)DownloadHi-Res Photo
About
Copy Link
Titles
Assistant Professor Adjunct of Medicine (Digestive Diseases)
Biography
Badr Al Bawardy, MD, is a gastroenterologist at Yale Medicine specializing in inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis. He performs the following procedures: esophagogastroduodenoscopy (a diagnostic endoscopic procedure for the upper digestive tract, also known as EGD), colonoscopy, chromoendoscopy, and video capsule endoscopy.
Dr. Al Bawardy earned his M.D. with distinction from the George Washington University. After medical school, he completed an internal medicine residency, gastroenterology fellowship and a specialized inflammatory bowel disease fellowship at the Mayo Clinic in Rochester, MN, which gave him valuable experience treating the disease alongside leaders in the field.
IBD is a chronic medical condition affecting the gut, and often requires doctors to build long-term relationships with patients to manage their care. This type of medical care was appealing to Dr. Al Bawardy. He is a proponent of shared decision making in management of IBD. When meeting patients, Dr. Al Bawardy discusses risks, benefits, and goals of treatment with his patients so they can make an informed decision about their care. He also asks them about their preferences related to lifestyle and career, for example. He takes all this information into account when developing a treatment plan.
“My patient-care philosophy is that the patient always comes first,” he says.
In addition to caring for IBD patients, Dr. Al Bawardy’s clinical interests include evaluating and treating patients with celiac disease, microscopic colitis and general gastroenterology. Dr. Al Bawardy also conducts research and is an assistant professor of medicine (digestive diseases) at Yale School of Medicine.
Last Updated on May 23, 2025.
Appointments
Digestive Diseases
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- Digestive Diseases
- Internal Medicine
- Spondyloarthritis Program
- Yale Inflammatory Bowel Disease Center
- Yale Medicine
Education & Training
- IBD Fellow
- Mayo Clinic (2018)
- Fellow
- Mayo Clinic (2017)
- Resident
- Mayo Clinic (2014)
- MD
- The George Washington University (2011)
Research
Copy Link
Overview
Medical Research Interests
Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases; Treatment Outcome
ORCID
0000-0002-6102-9267
Research at a Glance
Yale Co-Authors
Frequent collaborators of Badr Al Bawardy's published research.
Publications Timeline
A big-picture view of Badr Al Bawardy's research output by year.
Research Interests
Research topics Badr Al Bawardy is interested in exploring.
Deborah Proctor, MD
Jill Gaidos, MD
Marie Robert, MD
Alyssa Ann Grimshaw, MBA, MLIS, MPH
Kenneth Hung, MD, MS
Louis Levine, MD, MEd
108Publications
1,132Citations
Inflammatory Bowel Diseases
Crohn Disease
Treatment Outcome
Colitis, Ulcerative
Publications
2025
Editorial: Redefining Safety in Post‐Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield
Quraishi M, Al‐Bawardy B. Editorial: Redefining Safety in Post‐Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield. Alimentary Pharmacology & Therapeutics 2025 PMID: 40820804, DOI: 10.1111/apt.70310.Peer-Reviewed Original ResearchCitationsOutcomes of Outpatient Advanced Therapy Exposed Patients Hospitalized With Severe Ulcerative Colitis
Al-Bawardy B, Al Sulais E, AlHarthi F, Mohamed G, Mukhtar M, Hart A, Raine T. Outcomes of Outpatient Advanced Therapy Exposed Patients Hospitalized With Severe Ulcerative Colitis. Crohn's & Colitis 360 2025, 7: otaf055. PMID: 40979857, PMCID: PMC12448430, DOI: 10.1093/crocol/otaf055.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRisk of colectomyRescue medical therapyLow albuminUlcerative colitisSevere UCColectomy rateDrug exposureMedical therapyRetrospective studyDisease severityAdvanced therapiesATE groupMultivariate analysisRetrospective study of adult patientsStudy of adult patientsHigh C-reactive proteinHigher colectomy rateMedian hospital lengthSevere ulcerative colitisCharacteristics of hospitalized patientsAssociated with colectomyC-reactive proteinLength of hospitalizationMeasures of disease severityLength of stayEfficacy and Safety of 1 L PEG-ASC Preparation for Colonoscopy in Patients with Inflammatory Bowel Diseases: A Multicenter Observational Study
Facciorusso A, Stasi E, Dell’Anna A, Brigida M, Gadour E, Almuhaidb A, Al-Bawardy B, Maida M, Sacco R. Efficacy and Safety of 1 L PEG-ASC Preparation for Colonoscopy in Patients with Inflammatory Bowel Diseases: A Multicenter Observational Study. Journal Of Clinical Medicine 2025, 14: 5043. PMID: 40725733, PMCID: PMC12295960, DOI: 10.3390/jcm14145043.Peer-Reviewed Original ResearchCitationsConceptsCleansing successInflammatory bowel disease patientsInflammatory bowel diseaseEndoscopic Score-Crohn's DiseaseBBPS scorePEG-AscBowel preparationPolyp detectionUlcerative colitisAdverse eventsPrimary outcomeObservational studyBowel diseaseRight colonColonoscopyMulticenter observational studySevere adverse eventsSES-CDScoresPolypsMayo scoreSecondary endpointsWell-toleratedSevere nauseaUC patientsCancer care for adolescents and young adults under the age of 50 in Saudi Arabia: policy review, research gaps, and future directions
Alessy S, Alghamdi M, Al-Bawardy B, Alghamdi S, Al-Hamoudi W, Alomaim W, Abaalkhail F, Alqarni A, Alsharm A, Alqurashi Y, Bokhary M, Alqahtani S. Cancer care for adolescents and young adults under the age of 50 in Saudi Arabia: policy review, research gaps, and future directions. EClinicalMedicine 2025, 85: 103188. PMID: 40741225, PMCID: PMC12308308, DOI: 10.1016/j.eclinm.2025.103188.Peer-Reviewed Original ResearchCitationsConceptsCancer incidence ratesPatient-centred careIncreasing cancer incidence ratesPublic health challengeYoung adultsSurvivorship carePsychological Well-BeingCancer carePsychosocial needsCare providersCancer ratesYears of ageHealthcare institutionsHealth challengesIncidence rateAYACareSaudi ArabiaUnified treatment protocolRisk factorsPolicy developmentPolicy reviewResearch initiativesTargeted researchAdultsDIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN’S DISEASE: A SYSTEMATIC REVIEW
Cohen N, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu M, Atreya R, Al-Bawardy B, Connor S, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon I, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin D, Silverberg M, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F. DIAGNOSIS AND MANAGEMENT OF UPPER GASTROINTESTINAL INVOLVEMENT IN ADULT PATIENTS WITH CROHN’S DISEASE: A SYSTEMATIC REVIEW. Clinical Gastroenterology And Hepatology 2025 PMID: 40378982, DOI: 10.1016/j.cgh.2025.03.024.Peer-Reviewed Original ResearchCitationsAltmetricConceptsJoanna Briggs InstituteCrohn's diseaseSystematic reviewAnti-TNF therapyIleocolonic Crohn's diseaseFull-text reviewStandard guidanceComprehensive systematic reviewUpper GI tractQuality appraisalAbdominal painAnti-TNFSymptomatic patientsClinical presentationGastrointestinal CDSurgical managementDiagnostic modalitiesClinical characteristicsAdult patientsOutcome measuresDisease locationStudy designMedian prevalencePatientsInterventional proceduresDouble Trouble: Leishmaniasis and Cytomegalovirus Colitis in an Immunocompromised Host
Alghaythi S, Almuhaidb A, Al-Bawardy B. Double Trouble: Leishmaniasis and Cytomegalovirus Colitis in an Immunocompromised Host. ACG Case Reports Journal 2025, 12: e01687. PMID: 40330504, PMCID: PMC12055041, DOI: 10.14309/crj.0000000000001687.Peer-Reviewed Original ResearchAltmetricConceptsCytomegalovirus colitisImmunocompromised patientsImmunocompromised hostsTransverse colonKidney transplantationHistopathological examinationUnusual localizationLesser curvatureSevere ulcerationFungal organismsWeight lossCytomegalovirusColitisUlcersVisceral leishmaniasisLeishmaniasisColonoscopyBiopsyMelenaProtozoan diseaseTransplantationGastroscopyPatientsSa1903: PREDICTORS AND OUTCOMES OF UPADACITINIB EXTENDED INDUCTION AND HIGHER DOSE MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE: A MULTICENTER STUDY
Johnkennedy R, Azar J, Levine L, AlOmar I, AlMutairdi A, Attamimi M, Proctor D, Gaidos J, Al-Bawardy B. Sa1903: PREDICTORS AND OUTCOMES OF UPADACITINIB EXTENDED INDUCTION AND HIGHER DOSE MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE: A MULTICENTER STUDY. Gastroenterology 2025, 169: s-575-s-576. DOI: 10.1016/s0016-5085(25)02265-6.Peer-Reviewed Original ResearchBASELINE PROGNOSTIC FACTORS OF BOWEL URGENCY IMPROVEMENT IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB
Dubinsky M, Schreiber S, Matsuoka K, Jairath V, Al-Bawardy B, Pellanda P, Zhu B, Bleakman A, Redondo I, Owen C, Limdi J. BASELINE PROGNOSTIC FACTORS OF BOWEL URGENCY IMPROVEMENT IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB. Inflammatory Bowel Diseases 2025, 31: s62-s63. DOI: 10.1093/ibd/izae282.147.Peer-Reviewed Original ResearchConceptsNumerical rating scalePain numerical rating scaleModified Mayo scoreMultivariate linear regression analysisInflammatory Bowel Disease QuestionnaireUnivariate analysisUlcerative colitisMayo scorePrognostic variablesAnti-IL-23p19 antibodyBaseline characteristics of patientsAnti-IL-23p19Linear regression analysisPhase 3 trialRegression analysisCharacteristics of patientsUrgency Numeric Rating ScaleBristol Stool ScaleMultivariate regression analysisPost Hoc AnalysisUnivariate analysis of associationPrognostic factorsDisease extentBaseline characteristicsMirikizumabMapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals’ Perspective: A Cross-Sectional Non-Interventional Study
Azzam N, Mosli M, Almutairdi A, Alghamdi M, Meeralam Y, Alolimi K, Arsalan M, Al-Bawardy B. Mapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals’ Perspective: A Cross-Sectional Non-Interventional Study. Journal Of Clinical Medicine 2025, 14: 1621. PMID: 40095549, PMCID: PMC11899997, DOI: 10.3390/jcm14051621.Peer-Reviewed Original ResearchConceptsComputer-assisted personal interviewsQuality of lifeGeneral practitionersPatient journeyTreatment goalsHealthcare professionals' perspectivesTNF-a inhibitorsInternal medicine physiciansBurden of ulcerative colitisUlcerative colitisClinical remissionImprovement of quality of lifeUC patientsOral systemic steroidsHealthcare professionalsSaudi ArabiaTNF-aPhysician responsesSurvey domainsYears of experienceProfessional perspectivesQuantitative interviewsTreating gastroenterologistImprove accessMedicine physiciansColorectal Neoplasia in Inflammatory Bowel Disease
Al Sulais E, AlAmeel T, Alenzi M, Shehab M, AlMutairdi A, Al-Bawardy B. Colorectal Neoplasia in Inflammatory Bowel Disease. Cancers 2025, 17: 665. PMID: 40002259, PMCID: PMC11853504, DOI: 10.3390/cancers17040665.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRisk of colonic neoplasiaColonic neoplasiaInflammatory bowel diseaseConcomitant primary sclerosing cholangitisRisk factorsMultiple risk factorsColorectal neoplasiaBowel diseaseHigh-risk featuresIncreased riskPrimary sclerosing cholangitisColonic Crohn's diseaseColonic dysplasiaDisease extentSclerosing cholangitisRiskCrohn's diseaseNeoplasiaUlcerative colitisDiseaseSurveillancePatientsColorectalEpidemiology
Academic Achievements & Community Involvement
Copy Link
Honors
honor Healthcare Honored Hero
05/01/2021Regional AwardCrohn's and Colitis Foundation, Connecticut/Westchester ChapterDetailsUnited Stateshonor Young Investigator Travel Grant Award
01/01/2020National AwardCrohn's and Colitis FoundationDetailsUnited Stateshonor Howard M. Spiro Fellowship Teaching Award
06/18/2019Yale School of Medicine AwardDigestive Diseases, Yale School of MedicineDetailsUnited Stateshonor Edward C Rosenow Award
05/01/2018Regional AwardDepartment of Internal Medicine. Mayo Clinic, Rochester, MNDetailsUnited Stateshonor Travel Grant Award
12/01/2017National AwardAdvances in Inflammatory Bowel Diseases ConferenceDetailsUnited States
News
Copy Link
News
- August 10, 2023
Ulcerative Colitis: Early Sigmoidoscopy & Clinical Outcomes (Discoveries & Impact August 2023)
- July 13, 2023
Oral Vancomycin as a Treatment Option for Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease (Discoveries & Impact July 2023)
- June 05, 2023
Yale Digestive Diseases Shares Latest Research in Chicago
- April 13, 2023
Discoveries & Impact (April 2023)